Proposal for a standardized PSA doubling-time calculation

Anticancer Res. 2010 May;30(5):1633-6.

Abstract

Purpose: Prostate-specific antigen (PSA) doubling-time (PSA-DT) is an important indicator of progression and survival in men with prostate cancer. Three major limitations regarding PSA-DT determination may lead to inconsistent results: the variety of mathematical methods currently applied, the non-standardized handling of input variables and the potential lack of accuracy due to PSA variability. The aim of this project was to develop a reproducible PSA-DT determination tool which simultaneously provides a PSA-DT error estimation.

Materials and methods: An internet-based PSA-DT calculation tool via nonlinear optimization implementing the least squares error method using the most recent three PSA values was developed. PSA-DT calculation error is estimated via randomly disturbed measurement data streams (n=65) based on a variable (5-25%) PSA variability.

Results: According to a simulation in five men, PSA-DT was calculated to be between 1.7 and 15 month (mean: 6.3 month) and determined with another standard tool between 1.3 and 14.5 month (mean: 4.2 month).

Conclusion: We present a defined, open and reproducible PSA-DT calculation and PSA-DT error estimation tool based on a standardized PSA data input. This tool is not better compared to other methods but is scientifically standardized and freely accessible via the following internet address: http://adam.drahtwarenhandlung.at/webapp/mg2008/chapter_prostata4/example_psa.

MeSH terms

  • Biomarkers, Tumor / biosynthesis
  • Clinical Laboratory Techniques*
  • Cohort Studies
  • Data Interpretation, Statistical
  • Humans
  • Kinetics
  • Least-Squares Analysis
  • Male
  • Models, Theoretical
  • Prognosis
  • Prostate-Specific Antigen / biosynthesis*
  • Prostatic Neoplasms / blood*
  • Prostatic Neoplasms / diagnosis*
  • Reproducibility of Results
  • Time Factors

Substances

  • Biomarkers, Tumor
  • Prostate-Specific Antigen